Login / Signup

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.

Nicolino RupertoHermine I BrunnerAthimalaipet V RamananGerd HorneffRubén CutticaMichael HenricksonJordi AntonAlina Lucica BoteanuInmaculada Calvo PenadesKirsten MindenHeinrike SchmelingMarkus HufnagelJennifer E WeissManuela PardeoKabita NandaJohannes RothNadina Rubio-PérezJoy C HsuSunethra WimalasunderaChris WellsKamal BharuchaWendy DouglassMin BaoNavita L MallalieuAlberto MartiniDaniel LovellFabrizio De Benedettinull null
Published in: Rheumatology (Oxford, England) (2021)
ClinicalTrials.gov, http://clinicaltrials.gov, NCT01904292 and NCT01904279.
Keyphrases
  • juvenile idiopathic arthritis
  • disease activity
  • young adults
  • rheumatoid arthritis
  • systemic lupus erythematosus